Sam68 is a novel marker for aggressive neuroblastoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Neuroblastoma (NB) is a common pediatric cancer with poor prognosis.
• The molecular drivers of NB progression remain largely unknown.
• Src-associated in mitosis with a molecular weight of 68 kDa (Sam68) is implicated in carcinogenesis and neurogenesis.

Purpose of the Study:

• To investigate the clinical and prognostic significance of Sam68 in neuroblastoma.
• To determine if Sam68 expression correlates with NB progression and patient outcomes.

Main Methods:

• Examined Sam68 expression (mRNA and protein) in NB cell lines and patient tissues using Western blotting and RT-PCR.
• Assessed NB cell proliferation via MTT assay.
• Analyzed Sam68 protein expression in 90 NB cases using immunohistochemistry and correlated with clinicopathological parameters.

Main Results:

• Sam68 expression was significantly higher in NB cell lines and tumor tissues compared to normal controls.
• Sam68 expression supported NB cell proliferation.
• Elevated Sam68 levels correlated with advanced clinical stage, tumor histology, and distant metastasis.
• Higher Sam68 expression was linked to shorter overall survival in NB patients.

Conclusions:

• Sam68 expression is significantly associated with neuroblastoma progression.
• Sam68 may serve as a novel and valuable prognostic biomarker for neuroblastoma patients.